52 /100
HIGH RISK
Score updated May 30, 2026

TNXP — Tonix Pharmaceuticals Holding Corp. Dilution Risk Tracker

Track TNXP dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track TNXP — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
60
💰 Cash Runway
10
📊 Float Risk
25
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

⛈️
Warning
High probability of dilution event
42%
🔁 Convertible Conversion 60%
• Major convertible overhang: 40% potential dilution
• Convertible risk score very high (85/100)
📉 Score Deterioration 40%
• Score rose 33 points recently (worsening)
🔔 Track TNXP — Get forecast alerts →

💹 Market Data

Market Cap$196.55M
Shares Outstanding15.94M
Float15.92M
Cash$185.47M
Debt$1.29M
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 60.0% shares (2025Q4 vs prior)
71 institutional holders · 3.91M shares
#1 BlackRock, Inc. 884.9K shares
#2 VANGUARD GROUP INC 673.6K shares
#3 Point72 Asset Management, L.P. 620.0K shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest2.34M
Days to Cover5.1
% of Float14.7%
FINRA data as of May 15, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Dec 31, 2024
xbrl XBRL CONVERTIBLE Dec 31, 2013
4 INSIDER TRANSACTION Apr 01, 2026
4 INSIDER TRANSACTION Mar 18, 2026
4 INSIDER TRANSACTION Feb 26, 2026
Full SEC filing analysis available with free account

📰 Recent News

No recent news
Track TNXP Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking TNXP — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
🔬 More Research for TNXP
📊 TNXP FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 TNXP Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.